INTRODUCTION    Blood transfusion after transcatheter aortic valve implantation (TAVI) is frequently required owing to the high vulnerability of this patient group and procedure‑related bleeding. OBJECTIVES    We assessed the impact of postprocedural blood transfusion and the age of transfused red blood cell (RBC) units on prognosis after TAVI. PATIENTS AND METHODS    This was a single‑center, observational analysis conducted between the years 2009 and 2014. The adopted endpoints were early and long‑term mortality after TAVI. The risk factors for mortality included in‑hospital bleeding and vascular complications, the number of transfused RBC units, transfusion of at least 2 RBC units, the age of transfused RBCs, and standard deviation of the age of RBCs. RESULTS    The study included 178 patients (mean [SD] age, 80.07 [7.47] years; range, 55–91 years). The follow‑up ranged between 1 month and 5.8 years (mean [SD], 20.1 [15.2] months) after discharge; 14 early deaths (7.8%) and 27 late deaths (16.5%) were noted. In‑hospital bleeding and vascular complications increased the risk of early deaths (hazard ratio [HR], 2.113; 95% CI, 1.011–4.418; P = 0.046 and HR, 2.265; 95% CI, 1.270–4.039; P = 0.005). Transfusion of younger RBCs (HR, 1.044; 95% CI, 1.004–1.085; P = 0.028) and a greater discrepancy in the age of transfused RBCs (HR, 1.153; 95% CI, 1.042–1.275; P = 0.006) were positively correlated with the risk of late deaths only in a univariate analysis. A higher number of transfused RBC units was the only independent predictor of long‑term mortality (HR, 1.149; 95% CI, 1.024–1.291; P = 0.018). CONCLUSIONS    The higher number of RBC units transfused early after TAVI worsens long‑term prognosis. Shorter‑storage RBCs and a greater discrepancy in RBC age in multitransfused elderly patients after TAVI might have a deleterious effect on life expectancy.